SKYSTAR

Pharmaceuticals, namely, small molecule therapeutic preparations for the correction of RNA expression, used in the treatment of cancers, neurological diseases, and other diseases, namely, cardiovascular diseases, immunological diseases, autoimmune diseases, neuromuscular diseases, blood disorders, rare genetic disorders and fibrosis; pharmaceuticals used in the treatment of cancers, neurological diseases, and other diseases, namely, cardiovascular diseases, immunological diseases, autoimmune diseases, neuromuscular diseases, blood disorders, rare genetic disorders and fibrosis